Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Austin

Showing results (541-550 of 640) with videos related to

Pageof 64
Sort By:
The New England Journal of Medicine|July 26, 2013
A novel channelopathy in pulmonary arterial hypertensionLijiang Ma, Danilo Roman-Campos, Eric D Austin, et al.
Circulation|March 24, 2016
Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial HypertensionEvan L Brittain, Megha Talati, Joshua P Fessel, et al.
Chest|February 20, 2021
ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical WorseningMegan Griffiths, Jun Yang, Catherine E Simpson, et al.
Plos One|January 14, 2021
The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine modelsArna Katewa, Eric Suto, Jessica Hui, et al.
Allergy|April 30, 2024
The effects of inhaled corticosteroids on healthy airwaysEmanuele Marchi, Timothy S C Hinks, Matthew Richardson, et al.
BMJ Open|July 14, 2025
Enhancing cognitive function in breast cancer survivors through community-based aerobic exercise training: protocol for a Hybrid Type I effectiveness-implementation study employing a randomised controlled designDiane K Ehlers, Jessica D Austin, Brenda Ernst, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2022
Deletion of a previously uncharacterized lipoprotein lirL confers resistance to an inhibitor of type II signal peptidase in <i>Acinetobacter baumannii</i>Ke-Jung Huang, Homer Pantua, Jingyu Diao, et al.
The Journal of Pediatrics|June 25, 2017
Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary DysplasiaUsha Krishnan, Jeffrey A Feinstein, Ian Adatia, et al.
Children (Basel, Switzerland)|May 27, 2026
Echocardiographic Detection of Pulmonary Hypertension and Right Ventricular Failure in Infants with Bronchopulmonary Dysplasia: A Survey of the BPD CollaborativeShilpa Vyas-Read, Shazia Bhombal, Roopa Siddaiah, et al.
Pediatric Research|September 14, 2020
Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survivalMegan Griffiths, Jun Yang, Melanie Nies, et al.
Pageof 64

Showing results (541-550 of 640) with videos related to

Sort By:
Pageof 64
The New England Journal of Medicine|July 26, 2013
A novel channelopathy in pulmonary arterial hypertensionLijiang Ma, Danilo Roman-Campos, Eric D Austin, et al.
Circulation|March 24, 2016
Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial HypertensionEvan L Brittain, Megha Talati, Joshua P Fessel, et al.
Chest|February 20, 2021
ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical WorseningMegan Griffiths, Jun Yang, Catherine E Simpson, et al.
Plos One|January 14, 2021
The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine modelsArna Katewa, Eric Suto, Jessica Hui, et al.
Allergy|April 30, 2024
The effects of inhaled corticosteroids on healthy airwaysEmanuele Marchi, Timothy S C Hinks, Matthew Richardson, et al.
BMJ Open|July 14, 2025
Enhancing cognitive function in breast cancer survivors through community-based aerobic exercise training: protocol for a Hybrid Type I effectiveness-implementation study employing a randomised controlled designDiane K Ehlers, Jessica D Austin, Brenda Ernst, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2022
Deletion of a previously uncharacterized lipoprotein lirL confers resistance to an inhibitor of type II signal peptidase in <i>Acinetobacter baumannii</i>Ke-Jung Huang, Homer Pantua, Jingyu Diao, et al.
The Journal of Pediatrics|June 25, 2017
Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary DysplasiaUsha Krishnan, Jeffrey A Feinstein, Ian Adatia, et al.
Children (Basel, Switzerland)|May 27, 2026
Echocardiographic Detection of Pulmonary Hypertension and Right Ventricular Failure in Infants with Bronchopulmonary Dysplasia: A Survey of the BPD CollaborativeShilpa Vyas-Read, Shazia Bhombal, Roopa Siddaiah, et al.
Pediatric Research|September 14, 2020
Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survivalMegan Griffiths, Jun Yang, Melanie Nies, et al.
Pageof 64